Ito Yuri, Ioka Akiko, Tsukuma Hideaki, Ajiki Wakiko, Sugimoto Tomoyuki, Rachet Bernard, Coleman Michel P
Department of Cancer Control and Statistics, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan.
Cancer Sci. 2009 Jul;100(7):1306-11. doi: 10.1111/j.1349-7006.2009.01170.x. Epub 2009 Apr 21.
We used new methods to examine differences in population-based cancer survival between six prefectures in Japan, after adjustment for age and stage at diagnosis. We applied regression models for relative survival to data from population-based cancer registries covering each prefecture for patients diagnosed with stomach, lung, or breast cancer during 1993-1996. Funnel plots were used to display the excess hazard ratio (EHR) for each prefecture, defined as the excess hazard of death from each cancer within 5 years of diagnosis relative to the mean excess hazard (in excess of national background mortality by age and sex) in all six prefectures combined. The contribution of age and stage to the EHR in each prefecture was assessed from differences in deviance-based R(2) between the various models. No significant differences were seen between prefectures in 5-year survival from breast cancer. For cancers of the stomach and lung, EHR in Osaka prefecture were above the upper 95% control limits. For stomach cancer, the age- and stage-adjusted EHR in Osaka were 1.29 for men and 1.43 for women, compared with Fukui and Yamagata. Differences in the stage at diagnosis of stomach cancer appeared to explain most of this excess hazard (61.3% for men, 56.8% for women), whereas differences in age at diagnosis explained very little (0.8%, 1.3%). This approach offers the potential to quantify the impact of differences in stage at diagnosis on time trends and regional differences in cancer survival. It underlines the utility of population-based cancer registries for improving cancer control.
我们采用新方法,在对诊断时的年龄和分期进行调整后,研究了日本六个县基于人群的癌症生存率差异。我们将相对生存回归模型应用于1993 - 1996年期间诊断为胃癌、肺癌或乳腺癌的患者的基于人群的癌症登记数据,这些数据涵盖了每个县。漏斗图用于展示每个县的超额风险比(EHR),其定义为诊断后5年内每种癌症的超额死亡风险相对于所有六个县合并后的平均超额风险(超过按年龄和性别划分的全国背景死亡率)。根据不同模型之间基于偏差的R(2)差异,评估年龄和分期对每个县EHR的贡献。各县之间乳腺癌5年生存率未见显著差异。对于胃癌和肺癌,大阪县的EHR高于95%的控制上限。对于胃癌,与福井县和山形县相比,大阪县经年龄和分期调整后的男性EHR为1.29,女性为1.43。胃癌诊断分期的差异似乎解释了大部分这种超额风险(男性为61.3%,女性为56.8%),而诊断年龄的差异解释得很少(分别为0.8%和1.3%)。这种方法有可能量化诊断分期差异对癌症生存时间趋势和地区差异的影响。它强调了基于人群的癌症登记对于改善癌症控制的实用性。